Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 13
244
Views
3
CrossRef citations to date
0
Altmetric
Articles

Chiroptical study and absolute configuration of securinine oxidation products

, , , , , , , & show all
Pages 1235-1242 | Received 13 Jan 2015, Accepted 20 Feb 2015, Published online: 19 Mar 2015

References

  • Bondu S, Genta-Jouve G, Leiros M, Vale C, Guigonis J-M, Botana LM, Thomas OP. 2012. Additional bioactive guanidine alkaloids from the Mediterranean sponge Crambe crambe. RSC Adv. 2:2828–2835. doi:10.1039/c2ra00045h.
  • Bruhn T, Schaumlöffel A, Hemberger Y, Bringmann G. 2013. SpecDis: quantifying the comparison of calculated and experimental electronic circular dichroism spectra. Chirality. 25:243–249. doi:10.1002/chir.22138.
  • Cachet N, Genta-Jouve G, Regalado EL, Mokrini R, Amade P, Culioli G, Thomas OP. 2009. Parazoanthines A–E, hydantoin alkaloids from the Mediterranean sea anemone Parazoanthus axinellae. J Nat Prod. 72:1612–1615. doi:10.1021/np900437y.
  • Chirkin E, Atkatlian W, Porée F-H. 2015. The securinega alkaloids. In: Knölker HJ, editor. The alkaloids. New York: Academic Press; Vol 74, pp. 1–120. https://doi.org/doi:10.1016/bs.alkal.2014.11.001.
  • Genta-Jouve G, Thomas OP. 2013. Absolute configuration of the new 3-epi-cladocroic acid from the Mediterranean sponge Haliclona fulva. Metabolites. 3:24–32. doi:10.3390/metabo3010024.
  • Genta-Jouve G, Weinberg L, Cocandeau V, Maestro Y, Thomas OP, Holderith S. 2013. Revising the absolute configurations of coatlines via density functional theory calculations of electronic circular dichroism spectra. Chirality. 25:180–184. doi:10.1002/chir.22129.
  • Gupta K, Chakrabarti A, Rana S, Ramdeo R, Roth LBL, Agarwal LML, Tse W, Agarwal KMK, Wald NDN, Minna D. 2011. Securinine, a myeloid differentiation agent with therapeutic potential for AML. PLOS ONE. 6:e21203. doi:10.1371/journal.pone.0021203.
  • Holmes M, Crater AK, Dhudshia B, Thadani AN, Ananvoranich S. 2011. Toxoplasma gondii: inhibitory activity and encystation effect of securinine and pyrrolidine derivatives on Toxoplasma growth. Exp Parasitol. 127:370–375. doi:10.1016/j.exppara.2010.09.002.
  • Horii Z, Imanishi T, Yamauchi M, Hanaoka M, Parello J, Munavalli S. 1972. Structure of phyllantidine. Tetrahedron Lett. 13:1877–1880. doi:10.1016/S0040-4039(01)84740-7.
  • Klochkov SG, Neganova ME, Afanas'eva SV, Shevtsova EF. 2014. Synthesis and antioxidant activity of securinine derivatives. Pharm Chem J. 48:15–17. doi:10.1007/s11094-014-1035-5.
  • Lajis NH, Guan OB, Sargent MV, Skelton BW, White AH. 1992. Viroallosecurinine and ent-phyllantidine from the leaves of Breynia coronata (Euphorbiaceae). Aust J Chem. 45:1893–1897.
  • Li J-Y, Zhao B-X, Zhang W, Li C, Huang X-J, Wang Y, Sun P-H, Ye W-C, Chen W-M. 2012. Unexpected ring contraction and oxidation rearrangement reactions of securinine. Tetrahedron. 68:3972–3979. doi:10.1016/j.tet.2012.03.084.
  • Livant PD, Beutler JA. 1987. Conformations of the securinine alkaloids as studied by high field 13C, 1H and 2-D NMR, and molecular mechanics calculation. Tetrahedron. 43:2915–2924. doi:10.1016/S0040-4020(01)86830-7.
  • Murav'eva VI, Ban'kovskii AI. 1956. Securinine a new alkaloid of strychnine-like action. Med Prom-st SSSR. 10:27–28.
  • Nakano T, Terao S, Lee KH, Saeki Y, Durham LJ. 1966. Some observations on the oxidation of virosecurinine with monoperphthalic acid 1,2. J Org Chem. 31:2274–2279. doi:10.1021/jo01345a044.
  • Nakano T, Yang TH, Terao S. 1962. Structure of virosecurinine. Chem Ind (London, UK). 1651–1652.
  • Parello J. 1965. Phyllantine et Phyllantidine, alcaloïdes du Phyllantus discoïdes Muell. Arg. (Euphorbiaceae) [Phyllantine and Phyllantidine, alkaloids from Phyllantus discoïdes Muell. Arg. (Euphorbiaceae)]. C.R. Acad Sci. 260:337–340.
  • Saito S, Iwamoto T, Tanaka T, Matsumura C, Sugimoto N, Horii Z, Tamura Y. 1964. Two new alkaloids, viroallosecurinine and virosine, isolated from Securinega virosa. Chem Ind (London, UK). 1263–1264.
  • Satoda I, Murayama M, Tsuji J, Yoshii E. 1962. Studies on securinine and allosecurinine. Tetrahedron Lett. 3:1199–1206. doi:10.1016/S0040-4039(00)70585-5.
  • Snieckus V. 1973. The Securinega alkaloids. In: Manske RH, editor. The alkaloids. New York: Academic Press; Vol 14, p. 425–506.
  • Wald D. 2014. US Patent 2014/0018383 A1.
  • Wei H, Qiao C, Liu G, Yang Z, Li C-C. 2013. Stereoselective total syntheses of ( − )-flueggine a and (+)-virosaine b. Angew Chem Int Ed. 52:620–624. doi:10.1002/anie.201208261.
  • Weinreb SM. 2009. Total synthesis of the Securinega alkaloids. Nat Prod Rep. 26:758–775. doi:10.1039/b902265a.
  • Zhang W, Li J-Y, Lan P, Sun P-H, Wang L, Ye W-C, Chen WM. 2011. Chemical synthesis and biological activities of Securinega alkaloids. J Chin Pharm Sci. 20:203–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.